About ImmuneOncia Therapeutics Inc.

Sponsor retains sole responsibility for content.

ImmuneOncia was established as a joint venture between Sorrento Therapeutics, USA and Yuhan Corporation, Korea, focusing on immuno-oncology and aims to bring safe, effective immunotherapies to patients worldwide.

Contact ImmuneOncia Therapeutics Inc.

Phone Number

More About ImmuneOncia Therapeutics Inc.

Therapeutic Areas
  • Oncology
  • Other
Company Type
  • Pharmaceutical
State of Ownership
  • Private
Sponsorship Group
  • Networker